Tecan Group AG
TCHBF - Insider Information
Get informed when a big investor buys or sells
+ FollowMarket Cap$3.45B
Close$
$112.72
58.4% downside
Current Fair Value
58.4% downsideOvervalued by 58.4% based on the discounted cash flow analysis.
Insider Trades
Loading insider trades…
Congress Trades
Loading congress trades…
Share Statistics
| Market cap | $3.45 Billion |
|---|---|
| Enterprise Value | $3.61 Billion |
| Annual dividend | $1.93 |
| Dividend yield | 1.22% |
| Earnings per Share | $-8.74 |
| Beta | 1.08 |
| Outstanding Shares | 12,395,959 |
Return
| Return on Equity | -4.77% |
|---|---|
| Return on Assets | -3.23% |
| Return on Invested Capital | 8.68% |
Valuation & Multiples
| P/E Ratio | -26.79 |
|---|---|
| PEG | 83.95 |
| Price to Sales | 1.9 |
| Price to Book Ratio | 3.01 |
| Enterprise Value to Revenue | 2.04 |
| Enterprise Value to EBIT | 30.47 |
| Enterprise Value to Net Income | -68 |
| Total Debt to Enterprise | 0.08 |
| Debt to Equity | 0.26 |
Revenue Sources
No data
Last Earnings Call
Report Date
August 11, 2026
EPS Estimate
$3.11
Consensus analyst estimateRevenue Estimate
$529.78 M
Consensus analyst estimateNext Earnings Call
Expected Date
March 16, 2027
EPS Estimate
$4.29
Consensus analyst estimateRevenue Estimate
$553.14 M
Consensus analyst estimateInstitutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
About Tecan Group AG
3,244 employees
CEO: Monica Manotas
Tecan Group AG, established in 1980 and based in Männedorf, Switzerland, provides advanced laboratory instruments and comprehensive solutions. The company caters to a wide range of clients globally, including pharmaceutical and biotechno...